DRW Securities’s Heart Test Laboratories HSCS Stock Holding History

DRW Securities’s Portfolio HSCS Stock Details HSCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-76,450	Closed	-$192K	–	1182
2026 Q1	$192K	Sell	76,450 -18,615	-20%	-$54.2K	﹤0.01%	1128
2025 Q4	$294K	Buy	95,065 +11,455	+14%	+$34K	0.01%	693
2025 Q3	$291K	Buy	+83,610	New	+$304K	0.01%	861

Other funds holding HSCS

TFB Advisors Overland Park, Kansas $227M AUM 26.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

ASW

Astoria Strategic Wealth Conroe, Texas $438M AUM 16.79% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

TWM

Tradition Wealth Management Edina, Minnesota $1.64B AUM 26.59% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

Citigroup New York $303B AUM 53.02% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

DRW Securities's HSCS Position: Q2 2026 in Review

DRW Securities sold out of Heart Test Laboratories (HSCS) in Q2 2026, closing a stake of 76,450 shares — an estimated $192K sold.

DRW Securities first reported a position in HSCS in Q3 2025 and held it in 3 quarters. The position peaked at $294K in Q4 2025. 16 funds tracked by Wall St. Rank hold HSCS as of Q2 2026.

DRW Securities reported no remaining Heart Test Laboratories position as of Q2 2026 after selling out during the quarter.
DRW Securities sold 76,450 Heart Test Laboratories shares in Q2 2026, an estimated $192K.
DRW Securities first reported a position in Heart Test Laboratories in Q3 2025 and held it in 3 quarters.
DRW Securities's Heart Test Laboratories position peaked at $294K in Q4 2025.
16 funds tracked by Wall St. Rank held Heart Test Laboratories as of Q2 2026.

Based on DRW Securities's 13F filing for Q2 2026, filed 14 Aug 2026.